Article
RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines
2 Oct 2019
Abstract excerpt
The success of checkpoint inhibitors in cancer therapy is largely attributed to activating the patient's immune response to their tumor's neoantigens arising from DNA mutations. This realization has motivated the interest in personal cancer vaccines based on sequencing the patient's tumor DNA to discover neoantigens. Here we propose an additional, unrecognized source of tumor neoantigens. We show that errors in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
